Identification Generic Name (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol DrugBank Accession Number DB07711 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol (DB07711) ×  Close Weight Average: 277.3653  Monoisotopic: 277.190260383  Chemical Formula C 14 H 23 N 5 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Adenosine deaminase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Imidazopyrimidines Sub Class Purines and purine derivatives Direct Parent 6-aminopurines Alternative Parents Aminopyrimidines and derivatives  /  N-substituted imidazoles  /  Imidolactams  /  Heteroaromatic compounds  /  Secondary alcohols  /  Azacyclic compounds  /  Primary amines  /  Organopnictogen compounds  /  Hydrocarbon derivatives Substituents 6-aminopurine  /  Alcohol  /  Amine  /  Aminopyrimidine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Azole  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imidazole Molecular Framework Aromatic heteropolycyclic compounds External Descriptors EHNA ( CHEBI:63059 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key IOSAAWHGJUZBOG-WDEREUQCSA-N InChI InChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m0/s1 IUPAC Name (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol SMILES [H][C@@](C)(O)[C@@]([H])(CCCCCC)N1C=NC2=C(N)N=CN=C12 References General References Not Available External Links PubChem Compound 149790 PubChem Substance 99444182 ChemSpider 132030 BindingDB 28393 ChEBI 63059 ChEMBL CHEMBL296435 ZINC ZINC000001558334 PDBe Ligand EH9 PDB Entries 2z7g  /  4c1i Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.44 mg/mL ALOGPS logP 2.1 ALOGPS logP 2.14 Chemaxon logS -2.8 ALOGPS pKa (Strongest Acidic) 14.8 Chemaxon pKa (Strongest Basic) 3.7 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 89.85 Å 2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 79.55 m 3 ·mol -1 Chemaxon Polarizability 31.05 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9937 Blood Brain Barrier + 0.8503 Caco-2 permeable - 0.5891 P-glycoprotein substrate Substrate 0.6841 P-glycoprotein inhibitor I Non-inhibitor 0.9067 P-glycoprotein inhibitor II Inhibitor 0.5468 Renal organic cation transporter Non-inhibitor 0.746 CYP450 2C9 substrate Non-substrate 0.8684 CYP450 2D6 substrate Non-substrate 0.8054 CYP450 3A4 substrate Non-substrate 0.6184 CYP450 1A2 substrate Non-inhibitor 0.7691 CYP450 2C9 inhibitor Non-inhibitor 0.907 CYP450 2D6 inhibitor Non-inhibitor 0.9231 CYP450 2C19 inhibitor Non-inhibitor 0.9026 CYP450 3A4 inhibitor Non-inhibitor 0.8309 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5795 Ames test Non AMES toxic 0.5475 Carcinogenicity Non-carcinogens 0.8999 Biodegradation Not ready biodegradable 0.9923 Rat acute toxicity 2.6773 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8181 hERG inhibition (predictor II) Non-inhibitor 0.7205    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References Ki (nM) 2 N/A N/A A28548 
 
 
  Details 
 
 
   Binding Properties 1.  Adenosine deaminase Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine. Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, an... Gene Name ADA Uniprot ID P00813 Uniprot Name Adenosine deaminase Molecular Weight 40764.13 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52 